Very-Low-Energy Ketogenic Therapy Modulates the Metabolic-Antioxidant Axis in Patients with Obesity and Type 2 Diabetes: A Non-Randomized Clinical Trial.

Antioxidants (Basel) · 2026 · PMC13404200 · PMID 42510575

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.060so close (0.05 < p ≤ 0.1)

Within-group analyses showed a trend toward relative reductions in IL-6 in both the control (−24.4%; p = 0.060) and the VLEKT groups (−21.3%; p = 0.098).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.